HANNAH REEVES: Open Payments
NPI 1982953949 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 9 payments from 6 companies in 2025. Trend: 2023 $192 · 2024 $345 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| Amgen Inc. | 2 | $36 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
Products named: OTEZLA, NEMLUVIO, COSENTYX, DUPIXENT, SPEVIGO, Zoryve.
Industry payments across AL — which companies pay providers there.
